BRIVIACT 10 MG TABLET

$23.9859per EA

DEA Schedule CV

Strength

10 mg/1

Manufacturer

NDC

50474037066

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

5/12/2016

Pharmacological Classes

Epoxide Hydrolase Inhibitors

0.0%

+2.6%

+2.0%

N/A

All

+4.3%

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Same classification

No related drugs found.